Clinical Trial Update: Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a pantoprazole formulation to the currently marketed pantoprazole tablet in patients with gastroesophageal reflux disease and erosive es…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (Protonix) (pantoprazole)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Gastroesophageal Reflux, Esophagitis | Phase 3 | Status: COMPLETED